Click for best price
Andrographis Paniculata Medicine Market Size, Share 2024
This research report provides a comprehensive analysis of the Andrographis Paniculata Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Andrographis Paniculata Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Andrographis Paniculata Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Andrographis Paniculata Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Andrographis Paniculata Medicine market presents opportunities for various stakeholders, including Hospital Clinic, Brick and Mortar Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Andrographis Paniculata Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Andrographis Paniculata Medicine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
Clinical needs: Andrographis paniculata has the functions of clearing heat, detoxifying, reducing inflammation, reducing swelling and relieving pain. It has a wide range of clinical applications, especially in the treatment of respiratory diseases such as colds, coughs, pharyngitis, and pneumonia. As the incidence of these diseases increases, the clinical demand for Andrographis paniculata drugs continues to increase, promoting the development of Andrographis paniculata drugs.
Key Features:
The research report on the Andrographis Paniculata Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Andrographis Paniculata Medicine market.
Market Overview: The report provides a comprehensive overview of the Andrographis Paniculata Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Tablet, Pill), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Andrographis Paniculata Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Andrographis Paniculata Medicine market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Andrographis Paniculata Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Andrographis Paniculata Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Andrographis Paniculata Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Andrographis Paniculata Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Andrographis Paniculata Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Andrographis Paniculata Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Andrographis Paniculata Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Market segment by Application
- Hospital Clinic
- Brick and Mortar Pharmacy
- Online Pharmacy
Global Andrographis Paniculata Medicine Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Tasly Group
- Baiyunshan Pharmaceutical
- Tongrentang
- Changchun People Pharmaceutical
- Wantong Pharmaceutical
- Yiling Pharmaceutical
- Shibiao Pharmaceutical
- Sunflower Pharmaceutical
- CSPC Pharmaceutical Group
- Nuojin Pharmaceutical
- ECHENG
- Renhe Pharmaceutical
- Furen Pharmaceutical
- Jiuhui Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Andrographis Paniculata Medicine, market overview.
Chapter 2: Global Andrographis Paniculata Medicine market size in revenue and volume.
Chapter 3: Detailed analysis of Andrographis Paniculata Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Andrographis Paniculata Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Andrographis Paniculata Medicine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Andrographis Paniculata Medicine Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
123 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Andrographis Paniculata Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Andrographis Paniculata Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Andrographis Paniculata Medicine Overall Market Size
2.1 Global Andrographis Paniculata Medicine Market Size: 2023 VS 2030
2.2 Global Andrographis Paniculata Medicine Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Andrographis Paniculata Medicine Sales: 2019-2030
3 Company Landscape
3.1 Top Andrographis Paniculata Medicine Players in Global Market
3.2 Top Global Andrographis Paniculata Medicine Companies Ranked by Revenue
3.3 Global Andrographis Paniculata Medicine Revenue by Companies
3.4 Global Andrographis Paniculata Medicine Sales by Companies
3.5 Global Andrographis Paniculata Medicine Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Andrographis Paniculata Medicine Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Andrographis Paniculata Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Andrographis Paniculata Medicine Players in Global Market
3.8.1 List of Global Tier 1 Andrographis Paniculata Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Andrographis Paniculata Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Andrographis Paniculata Medicine Market Size Markets, 2023 & 2030
4.1.2 Tablet
4.1.3 Pill
4.1.4 Capsule
4.2 By Type - Global Andrographis Paniculata Medicine Revenue & Forecasts
4.2.1 By Type - Global Andrographis Paniculata Medicine Revenue, 2019-2024
4.2.2 By Type - Global Andrographis Paniculata Medicine Revenue, 2025-2030
4.2.3 By Type - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
4.3 By Type - Global Andrographis Paniculata Medicine Sales & Forecasts
4.3.1 By Type - Global Andrographis Paniculata Medicine Sales, 2019-2024
4.3.2 By Type - Global Andrographis Paniculata Medicine Sales, 2025-2030
4.3.3 By Type - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
4.4 By Type - Global Andrographis Paniculata Medicine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Andrographis Paniculata Medicine Market Size, 2023 & 2030
5.1.2 Hospital Clinic
5.1.3 Brick and Mortar Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Andrographis Paniculata Medicine Revenue & Forecasts
5.2.1 By Application - Global Andrographis Paniculata Medicine Revenue, 2019-2024
5.2.2 By Application - Global Andrographis Paniculata Medicine Revenue, 2025-2030
5.2.3 By Application - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
5.3 By Application - Global Andrographis Paniculata Medicine Sales & Forecasts
5.3.1 By Application - Global Andrographis Paniculata Medicine Sales, 2019-2024
5.3.2 By Application - Global Andrographis Paniculata Medicine Sales, 2025-2030
5.3.3 By Application - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
5.4 By Application - Global Andrographis Paniculata Medicine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Andrographis Paniculata Medicine Market Size, 2023 & 2030
6.2 By Region - Global Andrographis Paniculata Medicine Revenue & Forecasts
6.2.1 By Region - Global Andrographis Paniculata Medicine Revenue, 2019-2024
6.2.2 By Region - Global Andrographis Paniculata Medicine Revenue, 2025-2030
6.2.3 By Region - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
6.3 By Region - Global Andrographis Paniculata Medicine Sales & Forecasts
6.3.1 By Region - Global Andrographis Paniculata Medicine Sales, 2019-2024
6.3.2 By Region - Global Andrographis Paniculata Medicine Sales, 2025-2030
6.3.3 By Region - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Andrographis Paniculata Medicine Revenue, 2019-2030
6.4.2 By Country - North America Andrographis Paniculata Medicine Sales, 2019-2030
6.4.3 US Andrographis Paniculata Medicine Market Size, 2019-2030
6.4.4 Canada Andrographis Paniculata Medicine Market Size, 2019-2030
6.4.5 Mexico Andrographis Paniculata Medicine Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Andrographis Paniculata Medicine Revenue, 2019-2030
6.5.2 By Country - Europe Andrographis Paniculata Medicine Sales, 2019-2030
6.5.3 Germany Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.4 France Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.5 U.K. Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.6 Italy Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.7 Russia Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.8 Nordic Countries Andrographis Paniculata Medicine Market Size, 2019-2030
6.5.9 Benelux Andrographis Paniculata Medicine Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Andrographis Paniculata Medicine Revenue, 2019-2030
6.6.2 By Region - Asia Andrographis Paniculata Medicine Sales, 2019-2030
6.6.3 China Andrographis Paniculata Medicine Market Size, 2019-2030
6.6.4 Japan Andrographis Paniculata Medicine Market Size, 2019-2030
6.6.5 South Korea Andrographis Paniculata Medicine Market Size, 2019-2030
6.6.6 Southeast Asia Andrographis Paniculata Medicine Market Size, 2019-2030
6.6.7 India Andrographis Paniculata Medicine Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Andrographis Paniculata Medicine Revenue, 2019-2030
6.7.2 By Country - South America Andrographis Paniculata Medicine Sales, 2019-2030
6.7.3 Brazil Andrographis Paniculata Medicine Market Size, 2019-2030
6.7.4 Argentina Andrographis Paniculata Medicine Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Andrographis Paniculata Medicine Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Andrographis Paniculata Medicine Sales, 2019-2030
6.8.3 Turkey Andrographis Paniculata Medicine Market Size, 2019-2030
6.8.4 Israel Andrographis Paniculata Medicine Market Size, 2019-2030
6.8.5 Saudi Arabia Andrographis Paniculata Medicine Market Size, 2019-2030
6.8.6 UAE Andrographis Paniculata Medicine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Tasly Group
7.1.1 Tasly Group Company Summary
7.1.2 Tasly Group Business Overview
7.1.3 Tasly Group Andrographis Paniculata Medicine Major Product Offerings
7.1.4 Tasly Group Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.1.5 Tasly Group Key News & Latest Developments
7.2 Baiyunshan Pharmaceutical
7.2.1 Baiyunshan Pharmaceutical Company Summary
7.2.2 Baiyunshan Pharmaceutical Business Overview
7.2.3 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.2.4 Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.2.5 Baiyunshan Pharmaceutical Key News & Latest Developments
7.3 Tongrentang
7.3.1 Tongrentang Company Summary
7.3.2 Tongrentang Business Overview
7.3.3 Tongrentang Andrographis Paniculata Medicine Major Product Offerings
7.3.4 Tongrentang Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.3.5 Tongrentang Key News & Latest Developments
7.4 Changchun People Pharmaceutical
7.4.1 Changchun People Pharmaceutical Company Summary
7.4.2 Changchun People Pharmaceutical Business Overview
7.4.3 Changchun People Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.4.4 Changchun People Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.4.5 Changchun People Pharmaceutical Key News & Latest Developments
7.5 Wantong Pharmaceutical
7.5.1 Wantong Pharmaceutical Company Summary
7.5.2 Wantong Pharmaceutical Business Overview
7.5.3 Wantong Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.5.4 Wantong Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.5.5 Wantong Pharmaceutical Key News & Latest Developments
7.6 Yiling Pharmaceutical
7.6.1 Yiling Pharmaceutical Company Summary
7.6.2 Yiling Pharmaceutical Business Overview
7.6.3 Yiling Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.6.4 Yiling Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.6.5 Yiling Pharmaceutical Key News & Latest Developments
7.7 Shibiao Pharmaceutical
7.7.1 Shibiao Pharmaceutical Company Summary
7.7.2 Shibiao Pharmaceutical Business Overview
7.7.3 Shibiao Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.7.4 Shibiao Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.7.5 Shibiao Pharmaceutical Key News & Latest Developments
7.8 Sunflower Pharmaceutical
7.8.1 Sunflower Pharmaceutical Company Summary
7.8.2 Sunflower Pharmaceutical Business Overview
7.8.3 Sunflower Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.8.4 Sunflower Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.8.5 Sunflower Pharmaceutical Key News & Latest Developments
7.9 CSPC Pharmaceutical Group
7.9.1 CSPC Pharmaceutical Group Company Summary
7.9.2 CSPC Pharmaceutical Group Business Overview
7.9.3 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Major Product Offerings
7.9.4 CSPC Pharmaceutical Group Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.9.5 CSPC Pharmaceutical Group Key News & Latest Developments
7.10 Nuojin Pharmaceutical
7.10.1 Nuojin Pharmaceutical Company Summary
7.10.2 Nuojin Pharmaceutical Business Overview
7.10.3 Nuojin Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.10.4 Nuojin Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.10.5 Nuojin Pharmaceutical Key News & Latest Developments
7.11 ECHENG
7.11.1 ECHENG Company Summary
7.11.2 ECHENG Business Overview
7.11.3 ECHENG Andrographis Paniculata Medicine Major Product Offerings
7.11.4 ECHENG Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.11.5 ECHENG Key News & Latest Developments
7.12 Renhe Pharmaceutical
7.12.1 Renhe Pharmaceutical Company Summary
7.12.2 Renhe Pharmaceutical Business Overview
7.12.3 Renhe Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.12.4 Renhe Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.12.5 Renhe Pharmaceutical Key News & Latest Developments
7.13 Furen Pharmaceutical
7.13.1 Furen Pharmaceutical Company Summary
7.13.2 Furen Pharmaceutical Business Overview
7.13.3 Furen Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.13.4 Furen Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.13.5 Furen Pharmaceutical Key News & Latest Developments
7.14 Jiuhui Pharmaceutical
7.14.1 Jiuhui Pharmaceutical Company Summary
7.14.2 Jiuhui Pharmaceutical Business Overview
7.14.3 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Major Product Offerings
7.14.4 Jiuhui Pharmaceutical Andrographis Paniculata Medicine Sales and Revenue in Global (2019-2024)
7.14.5 Jiuhui Pharmaceutical Key News & Latest Developments
8 Global Andrographis Paniculata Medicine Production Capacity, Analysis
8.1 Global Andrographis Paniculata Medicine Production Capacity, 2019-2030
8.2 Andrographis Paniculata Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Andrographis Paniculata Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Andrographis Paniculata Medicine Supply Chain Analysis
10.1 Andrographis Paniculata Medicine Industry Value Chain
10.2 Andrographis Paniculata Medicine Upstream Market
10.3 Andrographis Paniculata Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Andrographis Paniculata Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Andrographis Paniculata Medicine in Global Market
Table 2. Top Andrographis Paniculata Medicine Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Andrographis Paniculata Medicine Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Andrographis Paniculata Medicine Revenue Share by Companies, 2019-2024
Table 5. Global Andrographis Paniculata Medicine Sales by Companies, (K Units), 2019-2024
Table 6. Global Andrographis Paniculata Medicine Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Andrographis Paniculata Medicine Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Andrographis Paniculata Medicine Product Type
Table 9. List of Global Tier 1 Andrographis Paniculata Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Andrographis Paniculata Medicine Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Andrographis Paniculata Medicine Sales (K Units), 2019-2024
Table 15. By Type - Global Andrographis Paniculata Medicine Sales (K Units), 2025-2030
Table 16. By Application ? Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Andrographis Paniculata Medicine Sales (K Units), 2019-2024
Table 20. By Application - Global Andrographis Paniculata Medicine Sales (K Units), 2025-2030
Table 21. By Region ? Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Andrographis Paniculata Medicine Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Andrographis Paniculata Medicine Sales (K Units), 2019-2024
Table 25. By Region - Global Andrographis Paniculata Medicine Sales (K Units), 2025-2030
Table 26. By Country - North America Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Andrographis Paniculata Medicine Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Andrographis Paniculata Medicine Sales, (K Units), 2019-2024
Table 29. By Country - North America Andrographis Paniculata Medicine Sales, (K Units), 2025-2030
Table 30. By Country - Europe Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Andrographis Paniculata Medicine Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Andrographis Paniculata Medicine Sales, (K Units), 2019-2024
Table 33. By Country - Europe Andrographis Paniculata Medicine Sales, (K Units), 2025-2030
Table 34. By Region - Asia Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Andrographis Paniculata Medicine Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Andrographis Paniculata Medicine Sales, (K Units), 2019-2024
Table 37. By Region - Asia Andrographis Paniculata Medicine Sales, (K Units), 2025-2030
Table 38. By Country - South America Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Andrographis Paniculata Medicine Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Andrographis Paniculata Medicine Sales, (K Units), 2019-2024
Table 41. By Country - South America Andrographis Paniculata Medicine Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Andrographis Paniculata Medicine Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Andrographis Paniculata Medicine Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Andrographis Paniculata Medicine Sales, (K Units), 2025-2030
Table 46. Tasly Group Company Summary
Table 47. Tasly Group Andrographis Paniculata Medicine Product Offerings
Table 48. Tasly Group Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Tasly Group Key News & Latest Developments
Table 50. Baiyunshan Pharmaceutical Company Summary
Table 51. Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 52. Baiyunshan Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Baiyunshan Pharmaceutical Key News & Latest Developments
Table 54. Tongrentang Company Summary
Table 55. Tongrentang Andrographis Paniculata Medicine Product Offerings
Table 56. Tongrentang Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Tongrentang Key News & Latest Developments
Table 58. Changchun People Pharmaceutical Company Summary
Table 59. Changchun People Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 60. Changchun People Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Changchun People Pharmaceutical Key News & Latest Developments
Table 62. Wantong Pharmaceutical Company Summary
Table 63. Wantong Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 64. Wantong Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Wantong Pharmaceutical Key News & Latest Developments
Table 66. Yiling Pharmaceutical Company Summary
Table 67. Yiling Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 68. Yiling Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Yiling Pharmaceutical Key News & Latest Developments
Table 70. Shibiao Pharmaceutical Company Summary
Table 71. Shibiao Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 72. Shibiao Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Shibiao Pharmaceutical Key News & Latest Developments
Table 74. Sunflower Pharmaceutical Company Summary
Table 75. Sunflower Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 76. Sunflower Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Sunflower Pharmaceutical Key News & Latest Developments
Table 78. CSPC Pharmaceutical Group Company Summary
Table 79. CSPC Pharmaceutical Group Andrographis Paniculata Medicine Product Offerings
Table 80. CSPC Pharmaceutical Group Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. CSPC Pharmaceutical Group Key News & Latest Developments
Table 82. Nuojin Pharmaceutical Company Summary
Table 83. Nuojin Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 84. Nuojin Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Nuojin Pharmaceutical Key News & Latest Developments
Table 86. ECHENG Company Summary
Table 87. ECHENG Andrographis Paniculata Medicine Product Offerings
Table 88. ECHENG Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. ECHENG Key News & Latest Developments
Table 90. Renhe Pharmaceutical Company Summary
Table 91. Renhe Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 92. Renhe Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Renhe Pharmaceutical Key News & Latest Developments
Table 94. Furen Pharmaceutical Company Summary
Table 95. Furen Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 96. Furen Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Furen Pharmaceutical Key News & Latest Developments
Table 98. Jiuhui Pharmaceutical Company Summary
Table 99. Jiuhui Pharmaceutical Andrographis Paniculata Medicine Product Offerings
Table 100. Jiuhui Pharmaceutical Andrographis Paniculata Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Jiuhui Pharmaceutical Key News & Latest Developments
Table 102. Andrographis Paniculata Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 103. Global Andrographis Paniculata Medicine Capacity Market Share of Key Manufacturers, 2022-2024
Table 104. Global Andrographis Paniculata Medicine Production by Region, 2019-2024 (K Units)
Table 105. Global Andrographis Paniculata Medicine Production by Region, 2025-2030 (K Units)
Table 106. Andrographis Paniculata Medicine Market Opportunities & Trends in Global Market
Table 107. Andrographis Paniculata Medicine Market Drivers in Global Market
Table 108. Andrographis Paniculata Medicine Market Restraints in Global Market
Table 109. Andrographis Paniculata Medicine Raw Materials
Table 110. Andrographis Paniculata Medicine Raw Materials Suppliers in Global Market
Table 111. Typical Andrographis Paniculata Medicine Downstream
Table 112. Andrographis Paniculata Medicine Downstream Clients in Global Market
Table 113. Andrographis Paniculata Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Andrographis Paniculata Medicine Segment by Type in 2023
Figure 2. Andrographis Paniculata Medicine Segment by Application in 2023
Figure 3. Global Andrographis Paniculata Medicine Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Andrographis Paniculata Medicine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Andrographis Paniculata Medicine Revenue, 2019-2030 (US$, Mn)
Figure 7. Andrographis Paniculata Medicine Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Andrographis Paniculata Medicine Revenue in 2023
Figure 9. By Type - Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 11. By Type - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 12. By Type - Global Andrographis Paniculata Medicine Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 15. By Application - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 16. By Application - Global Andrographis Paniculata Medicine Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Andrographis Paniculata Medicine Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Andrographis Paniculata Medicine Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 20. By Region - Global Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 21. By Country - North America Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 22. By Country - North America Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 23. US Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 28. Germany Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 29. France Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 37. China Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 41. India Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 43. By Country - South America Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 44. Brazil Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Andrographis Paniculata Medicine Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Andrographis Paniculata Medicine Sales Market Share, 2019-2030
Figure 48. Turkey Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Andrographis Paniculata Medicine Revenue, (US$, Mn), 2019-2030
Figure 52. Global Andrographis Paniculata Medicine Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Andrographis Paniculata Medicine by Region, 2023 VS 2030
Figure 54. Andrographis Paniculata Medicine Industry Value Chain
Figure 55. Marketing Channels
